(Press-News.org) Chicago, August 28, 2025 — Barbara Casadei, M.D., D.Phil., FRCP, FMedSci, FESC, Head of the National Heart and Lung Institute (NHLI) and British Heart Foundation Professor of Cardiovascular Medicine at Imperial College London has been appointed as the next Editor in Chief of JAMA Cardiology. Dr. Casadei will assume the role of editor in chief of JAMA Cardiology in early 2026.
Dr. Casadei will succeed Robert Bonow, MD, MS, who is the founding editor in chief of JAMA Cardiology and the Max and Lilly Goldberg Distinguished Professor at Northwestern University Feinberg School of Medicine.
With extensive experience in cardiovascular research, Dr. Casadei leads a “bench to bedside” research program with a focus on common cardiovascular diseases such as heart failure and atrial fibrillation. Dr. Casadei founded and co-chaired EuroHeart, an initiative supported by the European Society of Cardiology dedicated to assessing and improving quality of cardiovascular care in Europe. She is also the principal investigator of a cardiac monitoring study involving more than 35,000 participants in the UK Biobank imaging cohort, exploring the impact of clinically silent arrhythmias on AI-derived imaging parameters, cognitive decline, and the risk of cardioembolic stroke.
A leader in her field, Dr. Casadei serves on the boards of the Leducq Foundation in the US, Novo Nordisk Foundation in Denmark, Max Delbrück Centre for Molecular Medicine in Berlin, and CADENCE in Singapore. She holds honors from the British Cardiovascular Society (The Mackenzie Medal) and the European Society of Cardiology (Gold Medal). She is a past President of the European Society of Cardiology (2018-20).
Dr. Casadei holds a medical degree from the University of Pavia in Italy and a doctorate from the University of Oxford, where she is currently a Visiting Professor.
“I am honored to lead this prestigious journal together with a talented and energetic team,” said Dr. Casadei. “Our goals are to broaden the journal’s global impact, anticipate and drive the evolution of cardiology, and inspire and educate the next generation of health care professionals.”
JAMA Cardiology is an international, peer-reviewed journal that publishes research on cardiovascular medicine and surgery and is a member of the JAMA Network family of journals that includes JAMA and 11 other journals. JAMA Cardiology has a wide reach with more than 6 million annual article views and downloads. The Journal Impact Factor is 14.1, one of the highest ranking among cardiology journals.
“Dr. Casadei’s appointment marks our commitment to expanding the global reach and impact of JAMA Cardiology as a leading international cardiology journal,” said Kirsten Bibbins-Domingo, M.D., Ph.D., M.A.S., Editor in Chief of JAMA and the JAMA Network. “Dr. Casadei is an internationally recognized leader with extensive expertise, and I am excited to collaborate with her and build on the journal’s strong foundation established by its founding Editor in Chief Dr. Robert Bonow. I sincerely thank Dr. Bonow and his team of extraordinary editors and editorial board members for their vision in launching JAMA Cardiology and ensuring its remarkable success.”
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5252) or mediarelations@jamanetwork.org.
END
JAMA Network names new editor in chief of JAMA Cardiology
2025-08-28
ELSE PRESS RELEASES FROM THIS DATE:
DOD research aims to offer new solutions for ocular chemical injuries in military personnel
2025-08-28
DETROIT — Researchers at Wayne State University are pursuing new therapies for treating chemical injuries to the eyes with the help of a two-year, $400,400 grant from the U.S. Department of Defense (DOD).
Dr. Sukhvinder Singh, a research scientist in the laboratory of Dr. Ashok Kumar, professor of ophthalmology, visual and anatomical sciences at Wayne State University’s School of Medicine, has been awarded the grant, “Harnessing Immunometabolism to Ameliorate the Pathology of Ocular Chemical Injuries,” to support innovative studies into developing novel therapies ...
Novel therapy for pet cats with head and neck cancers could help humans, too
2025-08-28
Researchers have reported results from the first-ever clinical trial of a new class of targeted therapy in pet cats with head and neck squamous cell carcinoma (HNSCC)—a cancer which is notoriously deadly and difficult to treat. Publishing in the Cell Press journal Cancer Cell on August 28, the study found that 35% of the cats who received treatment had their disease controlled with minimal side effects—and the drug will likely be effective for humans with HNSCC as well.
“There are two major findings from this study,” says senior author Daniel Johnson of the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center. “It showed ...
Researchers develop novel treatment for central nervous system injury
2025-08-28
Traumatic injuries of the central nervous system (CNS)—such as traumatic brain injury (TBI) and traumatic spinal cord injury (SCI)—are characterized by oxidative damage and neuroinflammation. Current treatment relies mainly on supportive care and surgical intervention, with a lack of effective drugs to directly target the underlying damage.
For example, neural stem cell (NSC)-based therapy has shown therapeutic potential, but pathological microenvironments negatively impact NSC survival and directed differentiation, compromising therapeutic outcomes. Similarly, antioxidant treatment ...
Debt, bankruptcy, and credit scores after cancer diagnosis
2025-08-28
About The Study: In this retrospective cohort study, modest amounts of medical debt in collections persisted for years after cancer diagnosis. Total debt in collections was present at higher amounts for certain cancer subpopulations. The persistence of adverse financial outcomes after cancer diagnosis, despite high rates of insurance coverage in Massachusetts, warrants further research and consideration of broader systemic reforms.
Corresponding Author: To contact the corresponding author, Benjamin C. James, MD, MS, email bjames1@bidmc.harvard.edu.
To ...
Glucagon-like peptide-1 receptor agonists and risk of uveitis
2025-08-28
About The Study: This cohort study found that glucagon-like peptide-1 receptor agonist (GLP-1RA) prescriptions were associated with a lower risk of uveitis compared with controls. These findings suggest potential anti-inflammatory benefits beyond glycemic control, warranting further investigation into their role in ocular inflammatory diseases.
Corresponding Author: To contact the corresponding author, Sumit Sharma, MD, email sumitsharma.md@gmail.com.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaophthalmol.2025.2822)
Editor’s Note: Please see the article for additional ...
Study proposes new, more personalized methadone restart approach for opioid use disorder
2025-08-28
AURORA, Colo. (August 28, 2025) – A new study from University of Colorado Anschutz and Denver Health researchers, published today in JAMA Network Open, introduces a more individualized approach to restarting methadone treatment for people with opioid use disorder. The findings suggest that tailoring methadone doses to each patient’s unique circumstances can improve care without compromising safety.
Methadone is a proven medication that can cut the risk of death from opioid use disorder by about 50%. The researchers considered that current treatment protocols ...
Majority of oncology staff at Moroccan Cancer Institute affected by burnout
2025-08-28
“Burnout is highly prevalent among oncology healthcare professionals in Morocco, particularly among young female nurses.”
BUFFALO, NY — August 28, 2025 — A new research paper was published in Volume 12 of Oncoscience on July 31, 2025, titled “Burnout among oncology nurses and technicians in Morocco: Prevalence, risk factors, and structural equation modeling.”
In this study, Imane Errami, Saber Boutayeb, and Hassan Errihani from the Faculty of Medicine and Pharmacy at University Mohammed V of Rabat investigated ...
People who skip breakfast and eat late dinners may have a higher risk of osteoporosis
2025-08-28
WASHINGTON—People who skip breakfast and eat late dinners may have an increased risk of developing osteoporosis, according to a new study published in the Journal of the Endocrine Society.
Lifestyle habits, such as exercise, alcohol consumption and smoking, are known to increase people’s risk of osteoporosis, however little is known about the association between osteoporotic fracture and diet.
“This study aimed to examine the association between lifestyle habits such as diet, and the risk of osteoporotic fracture,” ...
Pertussis resurgence in Tuscany outlines importance of timely vaccination in Italy
2025-08-28
Pertussis, commonly known as whooping cough, is a vaccine-preventable disease which continues to circulate even in areas where vaccination coverage is high, and outbreaks may still occur. A study published in Eurosurveillance and conducted at Meyer Children’s Hospital in Florence, Italy, has found a sharp increase in hospitalisations for pertussis among children and adolescents (patients aged 16 years or under) in 2024. The findings highlight the critical role of not only adhering to vaccination schedules but also administering doses at the earliest opportunity to ensure a further reduction in cases and hospitalisations ...
Innovative food processing technologies: a path to nutritional efficiency in staple crops
2025-08-28
In a world where the demand for healthier diets is on the rise, a new review published in Engineering explores how innovative food processing technologies can enhance the utilization of nutrients in staple food crops. The study, titled "Innovative Food Processing Technologies Promoting Efficient Utilization of Nutrients in Staple Food Crops," delves into the challenges of traditional food processing methods and highlights the potential of modern techniques to improve nutritional profiles ...